Consistent with the stabilisation/reduction in M-protein in five patients, there was a decrease in the percentage of CD45dim CD38+++ MM cells in the bone marrow at the end of cycle 1 (P⩽0.05, Figure 3C). Here, MYOM2 is linked to Miyoshi myopathy.